Our senior leaders include the Brisbane Diamantina Health Partners Board, the Brisbane Diamantina Health Partners Executive and Theme Leaders.

BDHP Board

The Brisbane Diamantina Health Partners Board sets the strategic direction for Brisbane Diamantina Health Partners. Each partner is represented on the Board.


Sue Scheinpflug


BDHP Board Chairperson

view bio

Sue takes on the role as the BDHP Chairperson following three years as the CEO of Brisbane South Primary Health Network. She has over 20 years’ experience as a CEO, having worked in the areas of primary health care, mental health, homelessness, youth and families and education.  Sue is a community board member for the Parole Board Queensland, a member of the Queensland Mental Health Commission – Mental Health and Drug Advisory Council and a board member of West Moreton Health.

Sue has held numerous advisory and policy development roles and government appointments in the community services and regional development sectors.

Sue holds degrees in teaching and education and is a graduate of the Australian Institute of Company Directors.  She has won multiple awards as a business and community leader including the 2009 Queensland Telstra Business Woman of the Year Award.

Kerrie Freeman

Dr Kerrie Freeman

PG Dip Public Health, BBS, PhD

Chief Executive West Moreton Hospital and Health Service

view bio

Kerrie is a highly respected and experienced executive with over 15 years’ in leadership of health care delivery and transformative change.

She holds a Doctorate of Philosophy in Community Health, is a Graduate of the Australian Institute of Company Directors and holds an Adjunct Professorship at the University of Queensland.

Before joining West Moreton Health as Chief Executive, Kerrie led health services across the health care spectrum in Australia and New Zealand, including in rural and remote Queensland and quaternary health services at Children’s Health Queensland. She also has senior executive experience in purchasing health services, implementing large scale digital change, redeveloping hospital infrastructure and leading organisational cultural improvement.

Her passion is to serve the community, ensuring health services meet community needs and expectations by taking a population health approach to health strategy.

Scott Bell

Professor Scott Bell


Chief Executive Officer
Translational Research Institute

view bio

Professor Scott Bell is the Chief Executive of the Translational Research Institute and a Senior Physician of the Adult Cystic Fibrosis Centre at TPCH in Brisbane (>320 patients) where he has worked since 1996. He leads the Lung Bacteria Laboratory at UQ’s Children’s Health Research Centre. Scott has >250 peer reviewed publications and has received grant support >$22 million over the past 10 years. His research interests include the CF microbiology, acquisition pathways for human infection and has a long history of supporting multi-disciplinary research. He has been principal investigator on numerous pivotal CFTR modulator trials and is global principal investigator on a novel approach to combination therapies for CFTR correction. He has been the Editor-in-Chief of the Journal of Cystic Fibrosis since 2013.

Geoff McColl

Professor Geoff McColl


Executive Dean
Faculty of Medicine
The University of Queensland

view bio

Professor Geoff McColl is the Executive Dean of the Faculty of Medicine at the University of Queensland.  Prior to joining UQ, Geoff was the Head of the Melbourne Medical School at the University of Melbourne, where he led the development and implementation of the Melbourne MD.

Geoff completed his undergraduate medical training at the University of Melbourne and attained his FRACP in rheumatology in 1992 before completing a PhD focusing on rheumatoid arthritis at the Walter and Eliza Hall Institute in 1996.

Geoff is currently the Chair of the Australian Medical Council’s Medical School Assessment Committee, a member of the Therapeutic Goods Administration Advisory Committee on Medicines and a past member of Pharmaceutical Benefits Advisory Committee.

July 2, 2020. QIMR Berghofer Professor Fabienne Mackay. photo: QIMR Berghofer/Tony Phillips

Professor Fabienne Mackay

QIMR Berghofer

view bio

Professor Fabienne Mackay studied Medicine and Biomedical Engineering before she obtained her PhD in Molecular Biology and Immunology from Louis Pasteur University in Strasbourg, France. She is the Director and CEO of QIMR Berghofer Medical Research Institute in Queensland.  Prior to that, in 1994, she started her research career in the biotech industry at Biogen Inc. in Boston. She then arrived in Australia in 1999 when she joined the Garvan Institute in Sydney and became Director of the Autoimmunity Research Unit. In 2009, she was recruited as Head of the Department of Immunology at Monash University. In 2015, she became the inaugural Head of the School of Biomedical Sciences and Head of the Department of Pathology in the Faculty of Medicine, Dentistry and Health Sciences, at the University of Melbourne, Australia.

Her laboratory discovered the role of a very important factor, named BAFF in health but also in autoimmune diseases, findings described in very highly cited articles and providing the knowledge foundation for the development of a novel therapy called belimumab (BenlystaTM), and now approved for the treatment of patients with Systemic Lupus Erythematosus (SLE) and the first new treatment for SLE in over 50 years.  Professor Mackay’s group is focusing on inhibitors for the BAFF receptor TACI to treat Systemic Lupus Erythematosus (SLE) and Chronic Lymphocytic Leukaemia (CLL) without compromising key immune function. She has published over 170 articles cited 17,000 times. Her h-index is 65. She has published the world’s most highly cited work on BAFF. Her landmark study on the role of BAFF in SLE has been cited 1025 times.

She received the Thomson Reuters Australia Citation and Innovation award and a trophy from the French Ministry of Foreign Affairs in Paris for outstanding contribution in education and research as an expatriate. She also received the Martin Lackmann award for translational research and the William A. Paul Distinguished Innovator award from the Lupus Research Alliance (USA). She is an elected Council Member of the International Cytokine & Interferon Society, a member on the medical board of the Gairdner Foundation in Canada and an elected fellow of the Australian Academy of Health and Medical Sciences.


Dr Peter Steer

Group CEO
Mater Misericordiae Ltd

view bio

Peter was appointed Mater Group Chief Executive Officer in January 2019 and he brings with him a wealth of healthcare administration experience and clinical expertise.

Previously, Peter was the Chief Executive of Great Ormond Street Hospital for Children (GOSH) in London.

He commenced his medical career at Mater Brisbane in 1982 after graduating from The University of Queensland, and worked at Mater in Adults and Children’s Hospitals until 1987.

After a few years in New Zealand and Canada with further training in Neonatology, Peter returned to Mater Mothers’ and Children’s Hospitals in 1991 and continued until 2001.

Peter then spent further time at McMaster University and Hamilton Health Sciences in Canada before coming back to Brisbane where he was involved in the merger of Royal Children’s and Mater Children’s Hospitals as CEO of Children’s Health Queensland.

Frank Tracey

Adjunct, Associate Professor Frank Tracey

Chief Executive
Children’s Health Queensland Hospital and Health Service

view bio

Frank Tracey is the Health Service Chief Executive at Children’s Health Queensland Hospital and Health Service (CHQ HHS). Frank has more than 30 years’ experience working in health systems. This experience includes executive roles in large health organisations. Frank has a clinical background in nursing and holds advanced qualifications in health management and governance. His extensive experience in health commissioning and provision in clinical and community settings is complemented by strong managerial and leadership skills, and an applied interest in population health planning and translational health research. While working in both government and non-government roles Frank has focused on delivering sustainable health strategies that serve the best interests of patients, health professionals, the broader health system and the community.

Patsy Yates

Distinguished Professor Patsy Yates

Executive Dean – QUT Faculty of Health

view bio

Distinguished Professor Patsy Yates is a Registered Nurse with extensive experience as a leader in education and research in the health sector. Prior to her appointment as Executive Dean in 2020, Patsy was Professor and Head of the School of Nursing at QUT.

Patsy is also a Co-Director for QUT’s Centre for Healthcare Transformation. She leads a large competitively-funded research program focused on developing workforce capacity in cancer, palliative and aged care, advancing the management of cancer-related symptoms and treatment side effects, and strengthening the nexus between research, policy and practice in cancer,  palliative and aged care.

She holds visiting appointments as Lead Researcher for the Cancer Nursing Professorial Precinct at Royal Brisbane and Women’s Hospital, Director for Queensland Health’s statewide Centre for Palliative Care Research and Education, and Visiting Fellow at Princess Alexandra Hospital. She is also a Senior Fellow of the Centre for Health Outcomes and Policy Research, University of Pennsylvania.

Patsy is a Fellow of the American Academy of Nursing and the Australian College of Nursing.  She has been inducted into the International Nurse Researcher Hall of Fame of Sigma Theta Tau International Honour Society of Nursing and was awarded the prestigious USA Oncology Nursing Society Distinguished Researcher Award in 2018.  She has also received a Citation from the Australian Learning and Teaching Council for Outstanding Contribution to Student Learning.

Patsy is the current President of the International Society of Nurses in Cancer Care and a past-President of Palliative Care Australia.

John Upham

Professor John Upham

Metro South Health Chair
Metro South Research

view bio

John Upham is a respiratory physician and clinician scientist who thinks a lot about immune dysfunction in lung diseases.

After clinical training in Brisbane, John completed a PhD with the University of Western Australia followed by a post-doc fellowship at McMaster University in Canada. He returned to Brisbane in 2007 and holds appointments with Princess Alexandra Hospital and the University of Queensland. He was appointed Chair of Metro South Research in 2019.

His research interests include understanding the immune system in asthma, why people with chronic lung diseases are prone to virus infections, and developing targeted therapies for severe asthma.

Keith McNeil

Professor Keith McNeil

Acting Deputy Director-General and Chief Clinical Information Officer
Department of Health

view bio

Acting Deputy Director-General and Chief Clinical Information Officer Professor Keith McNeil plays a key role in the clinical leadership of the state-wide eHealth program. He works closely with key clinical stakeholders to maximise the clinical and patient safety benefits associated with technology in the healthcare setting.

Prof McNeil has previously worked within Queensland Health as the Head of Transplant Services at The Prince Charles Hospital, Chief Executive Officer at Royal Brisbane and Women’s Hospital, and Chief Executive Metro North Hospital and Health Service.

More recently, Prof McNeil was Chief Clinical Information Officer and Head of IT for the NHS in England following roles as Chief Executive Officer at Addenbooke’s Hospital and Cambridge University Hospital Foundation Trust.

Shaun Drummond

Shaun Drummond

Chief Executive, Metro North Hospital and Health Service

view bio

Shaun Drummond is the Chief Executive of Metro North. He has been Executive Director Operations of Metro North since 2014 and has been a Chief Operating Officer in the Health Sector for 15 years. Shaun’s professional background is Industrial Relations and Organisational Development. During his career he has worked in the public health system in New South Wales, Victoria, Queensland and New Zealand.

David - Copy 2

Dr David Hansen

Chief Executive Officer, Australian e-Health Centre

view bio

Dr David Hansen is CEO of the Australian e-Health Research Centre. David leads a research program of over 100 scientists and engineers developing information and communication technologies to improve the safety, quality and efficiency of healthcare.

David is a member of the Australian Digital Health Agency Clinical and Technical Advisory Committee, Co-Chair of the National Clinical Terminology Service, Member of the National Steering Committee for the Australian Genomics Health Alliance and Chair of the Health Informatics Society of Australia (HISA).

David is passionate about the role of information and communication technologies in health care and the role of Health Informatics professionals in developing a safe, efficient and sustainable healthcare system in Australia.

Theme Leaders

Our Theme Leaders play a critical role in developing, co-ordinating and leading our nine Themes.

David Paterson - Image

Professor David Paterson

Immunity, Inflammation, Infection theme


Professor Nancy Pachana

Ageing Theme


Professor Ranjeny Thomas

Immunity, Inflammation, Infection theme


Professor Steven Lane

Cancer Theme


Professor Euan Walpole

Cancer Theme


Professor H. Peter Soyer

Skin and Skin Cancer


Professor B. Mark Smithers

Skin and Skin Cancer Theme


Professor Ian Hector Frazer

Skin and Skin Cancer Theme


Professor Ian Yang

Chronic Disease Theme

Dr Ian Scott - Image

Associate Professor Ian Scott

Evidence and Innovation in Clinical Care Theme


Professor Karen Moritz

Maternal and Child Health Theme


Professor Jeffery Lipman

Trauma, Critical Care and Recovery Theme

Our Partners